Medications for Venous Thromboembolism (VTE)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Venous Thromboembolism (VTE).
Found 4 Approved Drugs for Venous Thromboembolism (VTE)
Xarelto
Generic Name
Rivaroxaban
Xarelto
Generic Name
Rivaroxaban
Form: Tablet, Kit, Granule, For
Method of administration: Oral
FDA approval date: July 01, 2011
Classification: Factor Xa Inhibitor
XARELTO is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation.
Apixaban
Brand Names
Eliquis 30-Day, Eliquis
Apixaban
Brand Names
Eliquis 30-Day, Eliquis
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: December 28, 2012
Classification: Factor Xa Inhibitor
Apixaban tablet is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Arixtra
Generic Name
Fondaparinux
Arixtra
Generic Name
Fondaparinux
Form: Injection
Method of administration: Subcutaneous
FDA approval date: July 14, 2011
Classification: Factor Xa Inhibitor
ARIXTRA is a Factor Xa inhibitor (anticoagulant) indicated for: Prophylaxis of deep vein thrombosis (DVT) in adult patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.
Fragmin
Generic Name
Dalteparin
Fragmin
Generic Name
Dalteparin
Form: Injection
Method of administration: Subcutaneous
FDA approval date: April 01, 2015
Classification: Low Molecular Weight Heparin
FRAGMIN is a low molecular weight heparin (LMWH) indicated for Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction.
Showing 1-4 of 4
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances